Abstract A232: In vitro and in vivo activity of NMS-E628 against ALK mutations resistant to Xalkori.Elena Ardini, Arturo Galvani, Luisa Rusconi et al.|Molecular Cancer Therapeutics|2011Cited by 20
In vitro and in vivo activity of NMS-E628 against ALK mutations resistant to Xalkori.Elena Ardini, Arturo Galvani, Maria Menichincheri et al.|Unknown|2011Cited by 11